This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhou, L J Articles by Tedder, T F Search for Related Content PubMed PubMed Citation Articles by Zhou, L J Articles by Tedder, T F

Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development.

Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, Massachusetts.

ABSTRACT

CD19 is a B-cell-specific member of the immunoglobulin superfamily expressed from early pre-B-cell development until plasma cell differentiation. In vitro studies demonstrate that the CD19 signal transduction molecule can serve as a costimulatory molecule for activation through other B-lymphocyte cell surface molecules. However, much remains to be known regarding how CD19 functions in vivo and whether CD19 has different roles at particular stages of B-cell differentiation. Therefore, transgenic mice overexpressing the human CD19 (hCD19) gene were generated to determine whether this transgene would be expressed in a B-lineage-specific fashion and to dissect the in vivo role of CD19 in B-cell development and activation. Expression of the human transgene product was specifically restricted to all B-lineage cells and appeared early in development as occurs with hCD19. In addition, expression of hCD19 severely impaired the development of immature B cells in the bone marrow, with dramatically fewer B cells found in the spleen, peripheral circulation, and peritoneal cavity. The level of hCD19 expressed on the cell surface correlated directly with the severity of the defect in different transgenic lines. These results demonstrate that the hCD19 gene is expressed in a lineage-specific fashion in mice, indicating that the hCD19 gene may be useful for mediating B-lineage-specific expression of other transgene products. In addition, these results indicate an important role for the lineage-specific CD19 molecule during early B-cell development before antigen-dependent activation.

This article has been cited by other articles:

• Xiu, Y., Wong, C. P., Bouaziz, J.-D., Hamaguchi, Y., Wang, Y., Pop, S. M., Tisch, R. M., Tedder, T. F. (2008). B Lymphocyte Depletion by CD20 Monoclonal Antibody Prevents Diabetes in Nonobese Diabetic Mice despite Isotype-Specific Differences in Fc{gamma}R Effector Functions. J. Immunol. 180: 2863-2875 [Abstract] [Full Text]  
• DiLillo, D. J., Hamaguchi, Y., Ueda, Y., Yang, K., Uchida, J., Haas, K. M., Kelsoe, G., Tedder, T. F. (2008). Maintenance of Long-Lived Plasma Cells and Serological Memory Despite Mature and Memory B Cell Depletion during CD20 Immunotherapy in Mice. J. Immunol. 180: 361-371 [Abstract] [Full Text]  
• Prazma, C. M., Yazawa, N., Fujimoto, Y., Fujimoto, M., Tedder, T. F. (2007). CD83 Expression Is a Sensitive Marker of Activation Required for B Cell and CD4+ T Cell Longevity In Vivo. J. Immunol. 179: 4550-4562 [Abstract] [Full Text]  
• Kaminski, D. A., Stavnezer, J. (2007). Antibody class switching differs among SJL, C57BL/6 and 129 mice. Int Immunol 19: 545-556 [Abstract] [Full Text]  
• Hamaguchi, Y., Xiu, Y., Komura, K., Nimmerjahn, F., Tedder, T. F. (2006). Antibody isotype-specific engagement of Fc{gamma} receptors regulates B lymphocyte depletion during CD20 immunotherapy. J. Exp. Med. 203: 743-753 [Abstract] [Full Text]  
• Lee, Y., Haas, K. M., Gor, D. O., Ding, X., Karp, D. R., Greenspan, N. S., Poe, J. C., Tedder, T. F. (2005). Complement Component C3d-Antigen Complexes Can Either Augment or Inhibit B Lymphocyte Activation and Humoral Immunity in Mice Depending on the Degree of CD21/CD19 Complex Engagement. J. Immunol. 175: 8011-8023 [Abstract] [Full Text]  
• Yazawa, N., Hamaguchi, Y., Poe, J. C., Tedder, T. F. (2005). Immunotherapy using unconjugated CD19 monoclonal antibodies in animal models for B lymphocyte malignancies and autoimmune disease. Proc. Natl. Acad. Sci. USA 102: 15178-15183 [Abstract] [Full Text]  
• Panagopoulos, D., Victoratos, P., Alexiou, M., Kollias, G., Mosialos, G. (2004). Comparative Analysis of Signal Transduction by CD40 and the Epstein-Barr Virus Oncoprotein LMP1 In Vivo. J. Virol. 78: 13253-13261 [Abstract] [Full Text]  
• Asano, N., Fujimoto, M., Yazawa, N., Shirasawa, S., Hasegawa, M., Okochi, H., Tamaki, K., Tedder, T. F., Sato, S. (2004). B Lymphocyte Signaling Established by the CD19/CD22 Loop Regulates Autoimmunity in the Tight-Skin Mouse. Am. J. Pathol. 165: 641-650 [Abstract] [Full Text]  
• Uchida, J., Hamaguchi, Y., Oliver, J. A., Ravetch, J. V., Poe, J. C., Haas, K. M., Tedder, T. F. (2004). The Innate Mononuclear Phagocyte Network Depletes B Lymphocytes through Fc Receptor-dependent Mechanisms during Anti-CD20 Antibody Immunotherapy. J. Exp. Med. 199: 1659-1669 [Abstract] [Full Text]  
• Ohtsuka, M., Arase, H., Takeuchi, A., Yamasaki, S., Shiina, R., Suenaga, T., Sakurai, D., Yokosuka, T., Arase, N., Iwashima, M., Kitamura, T., Moriya, H., Saito, T. (2004). NFAM1, an immunoreceptor tyrosine-based activation motif-bearing molecule that regulates B cell development and signaling. Proc. Natl. Acad. Sci. USA 101: 8126-8131 [Abstract] [Full Text]  
• Poe, J. C., Haas, K. M., Uchida, J., Lee, Y., Fujimoto, M., Tedder, T. F. (2004). Severely Impaired B Lymphocyte Proliferation, Survival, and Induction of the c-Myc:Cullin 1 Ubiquitin Ligase Pathway Resulting from CD22 Deficiency on the C57BL/6 Genetic Background. J. Immunol. 172: 2100-2110 [Abstract] [Full Text]  
• Uchida, J., Lee, Y., Hasegawa, M., Liang, Y., Bradney, A., Oliver, J. A., Bowen, K., Steeber, D. A., Haas, K. M., Poe, J. C., Tedder, T. F. (2004). Mouse CD20 expression and function. Int Immunol 16: 119-129 [Abstract] [Full Text]  
• Shoham, T., Rajapaksa, R., Boucheix, C., Rubinstein, E., Poe, J. C., Tedder, T. F., Levy, S. (2003). The Tetraspanin CD81 Regulates the Expression of CD19 During B Cell Development in a Postendoplasmic Reticulum Compartment. J. Immunol. 171: 4062-4072 [Abstract] [Full Text]  
• Yasutomo, K. (2003). Pathological lymphocyte activation by defective clearance of self-ligands in systemic lupus erythematosus. Rheumatology (Oxford) 42: 214-222 [Abstract] [Full Text]  
• Lawman, S, Ehrenstein, M R (2002). Many paths lead to lupus. Lupus 11: 801-806  
• Tolnay, M., Vereshchagina, L. A., Tsokos, G. C. (2002). NF-{kappa}B Regulates the Expression of the Human Complement Receptor 2 Gene. J. Immunol. 169: 6236-6243 [Abstract] [Full Text]  
• Marchbank, K. J., Kulik, L., Gipson, M. G., Morgan, B. P., Holers, V. M. (2002). Expression of Human Complement Receptor Type 2 (CD21) in Mice During Early B Cell Development Results in a Reduction in Mature B Cells and Hypogammaglobulinemia. J. Immunol. 169: 3526-3535 [Abstract] [Full Text]  
• Fujimoto, M., Poe, J. C., Satterthwaite, A. B., Wahl, M. I., Witte, O. N., Tedder, T. F. (2002). Complementary Roles for CD19 and Bruton's Tyrosine Kinase in B Lymphocyte Signal Transduction. J. Immunol. 168: 5465-5476 [Abstract] [Full Text]  
• Inabe, K., Kurosaki, T. (2002). Tyrosine phosphorylation of B-cell adaptor for phosphoinositide 3-kinase is required for Akt activation in response to CD19 engagement. Blood 99: 584-589 [Abstract] [Full Text]  
• Hasegawa, M., Fujimoto, M., Poe, J. C., Steeber, D. A., Tedder, T. F. (2001). CD19 Can Regulate B Lymphocyte Signal Transduction Independent of Complement Activation. J. Immunol. 167: 3190-3200 [Abstract] [Full Text]  
• Montrasio, F., Cozzio, A., Flechsig, E., Rossi, D., Klein, M. A., Rülicke, T., Raeber, A. J., Vosshenrich, C. A. J., Proft, J., Aguzzi, A., Weissmann, C. (2001). B lymphocyte-restricted expression of prion protein does not enable prion replication in prion protein knockout mice. Proc. Natl. Acad. Sci. USA 10.1073/pnas.051609398v1 [Abstract] [Full Text]  
• Sato, S., Hasegawa, M., Fujimoto, M., Tedder, T. F., Takehara, K. (2000). Quantitative Genetic Variation in CD19 Expression Correlates with Autoimmunity. J. Immunol. 165: 6635-6643 [Abstract] [Full Text]  
• Kleindienst, P., Chretien, I., Winkler, T., Brocker, T. (2000). Functional comparison of thymic B cells and dendritic cells in vivo. Blood 95: 2610-2616 [Abstract] [Full Text]  
• Fujimoto, M., Poe, J. C., Jansen, P. J., Sato, S., Tedder, T. F. (1999). CD19 Amplifies B Lymphocyte Signal Transduction by Regulating Src-Family Protein Tyrosine Kinase Activation. J. Immunol. 162: 7088-7094 [Abstract] [Full Text]  
• Maas, A., Dingjan, G. M., Grosveld, F., Hendriks, R. W. (1999). Early Arrest in B Cell Development in Transgenic Mice That Express the E41K Bruton's Tyrosine Kinase Mutant Under the Control of the CD19 Promoter Region. J. Immunol. 162: 6526-6533 [Abstract] [Full Text]  
• Fehr, T., Rickert, R. C., Odermatt, B., Roes, J., Rajewsky, K., Hengartner, H., Zinkernagel, R. M. (1998). Antiviral Protection and Germinal Center Formation, But Impaired B Cell Memory in the Absence of CD19. J. Exp. Med. 188: 145-155 [Abstract] [Full Text]  
• Buhl, A. M., Pleiman, C. M., Rickert, R. C., Cambier, J. C. (1997). Qualitative Regulation of B Cell Antigen Receptor Signaling by CD19: Selective Requirement for PI3-Kinase Activation, Inositol-1,4,5-Trisphosphate Production and Ca2+ Mobilization. J. Exp. Med. 186: 1897-1910 [Abstract] [Full Text]  
• Inaoki, M., Sato, S., Weintraub, B. C., Goodnow, C. C., Tedder, T. F. (1997). CD19-Regulated Signaling Thresholds Control Peripheral Tolerance and Autoantibody Production in B Lymphocytes. J. Exp. Med. 186: 1923-1931 [Abstract] [Full Text]  
• Lankester, A. C., Rood, P. M.L., van Schijndel, G. M.W., Hooibrink, B., Verhoeven, A. J., van Lier, R. A.W. (1996). Alteration of B-cell Antigen Receptor Signaling by CD19 Co-ligation. A STUDY WITH BISPECIFIC ANTIBODIES. J. Biol. Chem. 271: 22326-22330 [Abstract] [Full Text]  
• Fujimoto, M., Poe, J. C., Hasegawa, M., Tedder, T. F. (2001). CD19 Amplification of B Lymphocyte Ca2+ Responses. A ROLE FOR Lyn SEQUESTRATION IN EXTINGUISHING NEGATIVE REGULATION. J. Biol. Chem. 276: 44820-44827 [Abstract] [Full Text]  
• Montrasio, F., Cozzio, A., Flechsig, E., Rossi, D., Klein, M. A., Rulicke, T., Raeber, A. J., Vosshenrich, C. A. J., Proft, J., Aguzzi, A., Weissmann, C. (2001). B lymphocyte-restricted expression of prion protein does not enable prion replication in prion protein knockout mice. Proc. Natl. Acad. Sci. USA 98: 4034-4037 [Abstract] [Full Text]